From: Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014
Intervention | Number of studies |
---|---|
Biologic | 20 |
Corticosteroid | 8 |
Antiproliferative | 5 |
Alkylating agent | 4 |
Calcineurin antagonist | 12 |
Other immune modulator | 12 |
NSAID | 2 |
Anti-bacterial | 4 |
Drug acting on cardiovascular systema | 2 |
Other pharmacological interventionb | 5 |
Non-pharmacological interventionc | 6 |